QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.021691v1 70/1/214    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Halls, M. L. Articles by Summers, R. J. Search for Related Content PubMed PubMed Citation Articles by Halls, M. L. Articles by Summers, R. J.

Relaxin Family Peptide Receptors RXFP1 and RXFP2 Modulate cAMP Signaling by Distinct Mechanisms

Department of Pharmacology, Monash University, Clayton, Australia (M.L.H., R.J.S.); and Howard Florey Institute, Melbourne, Australia (R.A.D.B.)

Two orphan leucine-rich repeat-containing G protein-coupled receptors were recently identified as targets for the relaxin family peptides relaxin and insulin-like peptide (INSL) 3. Human gene 2 relaxin is the cognate ligand for relaxin family peptide receptor (RXFP) 1, whereas INSL3 is the ligand for RXFP2. Constitutively active mutants of both receptors when expressed in human embryonic kidney (HEK) 293T cells signal through G_s to increase cAMP. However, recent studies using cells that endogenously express the receptors revealed greater complexity: cAMP accumulation after activation of RXFP1 involves a time-dependent biphasic pathway with a delayed phase involving phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) , whereas the RXFP2 response involves inhibition of adenylate cyclase via pertussis toxin-sensitive G proteins. The aim of this study was to compare and contrast the cAMP signaling pathways used by these two related receptors. In HEK293T cells stably transfected with RXFP1, preliminary studies confirmed the biphasic cAMP response, with an initial G_s component and a delayed response involving PI3K and PKC. This delayed pathway was dependent upon G- subunits derived from G_i3. An additional inhibitory pathway involving G_oB affecting cAMP accumulation was also identified. In HEK293T cells stably transfected with RXFP2, the cAMP response involved G_s and was modulated by inhibition mediated by G_oB and release of inhibitory G- subunits. Thus, initially both RXFP1 and RXFP2 couple to G_s and an inhibitory G_oB pathway. Differences in cAMP accumulation stem from the ability of RXFP1 to recruit coupling to G_i3, release G- subunits and thus activate a delayed PI3K-PKC pathway to further increase cAMP accumulation.

Address correspondence to: Prof. Roger J. Summers, Department of Pharmacology, P.O. Box 13E, Monash University, Clayton, VIC 3800, Australia. E-mail: roger.summers{at}med.monash.edu.au

This article has been cited by other articles:

				G. E. Callander, W. G. Thomas, and R. A. D. Bathgate Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of {beta}-arrestin recruitment Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1058 - C1066. [Abstract] [Full Text] [PDF]

				I. Mookerjee, T. D. Hewitson, M. L. Halls, R. J. Summers, M. L. Mathai, R. A. D. Bathgate, G. W. Tregear, and C. S. Samuel Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2 FASEB J, April 1, 2009; 23(4): 1219 - 1229. [Abstract] [Full Text] [PDF]

				M. L. Halls, E. T. van der Westhuizen, J. D. Wade, B. A. Evans, R. A. D. Bathgate, and R. J. Summers Relaxin Family Peptide Receptor (RXFP1) Coupling to G{alpha}i3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains Mol. Pharmacol., February 1, 2009; 75(2): 415 - 428. [Abstract] [Full Text] [PDF]

				R. Shemesh, A. Toporik, Z. Levine, I. Hecht, G. Rotman, A. Wool, D. Dahary, E. Gofer, Y. Kliger, M. A. Soffer, et al. Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors J. Biol. Chem., December 12, 2008; 283(50): 34643 - 34649. [Abstract] [Full Text] [PDF]

				K. Heng, R. Ivell, P. Wagaarachchi, and R. Anand-Ivell Relaxin signalling in primary cultures of human myometrial cells Mol. Hum. Reprod., October 1, 2008; 14(10): 603 - 611. [Abstract] [Full Text] [PDF]

				Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606. [Abstract] [Full Text] [PDF]

				X.-l. Moore, S.-l. Tan, C.-y. Lo, L. Fang, Y.-D. Su, X.-M. Gao, E. A. Woodcock, R. J. Summers, G. W. Tregear, R. A. D. Bathgate, et al. Relaxin Antagonizes Hypertrophy and Apoptosis in Neonatal Rat Cardiomyocytes Endocrinology, April 1, 2007; 148(4): 1582 - 1589. [Abstract] [Full Text] [PDF]

				M. L. Halls, R. A. D. Bathgate, and R. J. Summers Comparison of Signaling Pathways Activated by the Relaxin Family Peptide Receptors, RXFP1 and RXFP2, Using Reporter Genes J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 281 - 290. [Abstract] [Full Text] [PDF]